RECENT EVENTS
2005/07/21 - The Canadian Genetic Diseases Network's 14th Annual Scientific Meeting - Celebrating 14 Years of Success
2004/11/01 - CGDN Contributes $1.47 Million to Cutting-Edge Genetic Research Projects
2004/10/18 - CGDN's role in advancing economic growth exemplified by $200 million deal
between Novartis and Xenon Pharmaceuticals
français
